HighTower Advisors’s Tiziana Life Sciences TLSA Stock Holding History

HighTower Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,130,001	Closed	-$2.47M	–	3668
2022 Q4	$2.47M	Hold	4,130,001	–	–	0.01%	1175
2022 Q3	$3.22M	Sell	4,130,001 -1,900	-0%	-$1.43K	0.01%	990
2022 Q2	$3.08M	Hold	4,131,901	–	–	0.01%	1029
2022 Q1	$4.34M	Hold	4,131,901	–	–	0.01%	964
2021 Q4	$3.97M	Buy	+4,131,901	New	+$5.48M	0.01%	1020
2021 Q3	–	Sell	-4,042,984	Closed	-$9.48M	–	3435
2021 Q2	$9.48M	Sell	4,042,984 -8,100	-0.2%	-$20K	0.03%	537
2021 Q1	$11.2M	Hold	4,051,084	–	–	0.04%	445
2020 Q4	$8.18M	Buy	4,051,084 +60,000	+2%	+$190K	0.03%	433
2020 Q3	$13.3M	Buy	3,991,084 +1,106,871	+38%	+$4.31M	0.06%	278
2020 Q2	$7.41M	Buy	2,884,213 +24,990	+0.9%	+$45.8K	0.04%	397
2020 Q1	$2.33M	Sell	2,859,223 -86,413	-3%	-$82.7K	0.02%	702
2019 Q4	$3.18M	Hold	2,945,636	–	–	0.02%	716
2019 Q3	$3.63M	Sell	2,945,636 -6,748	-0.2%	-$9.31K	0.02%	688
2019 Q2	$4.25M	Sell	2,952,384 -2,249	-0.1%	-$3.58K	0.03%	613
2019 Q1	$3.58M	Buy	2,954,633 +1,040,084	+54%	+$1.29M	0.02%	627
2018 Q4	$2.85M	Buy	+1,914,549	New	+$3.11M	0.02%	629

Other funds holding TLSA

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HighTower Advisors's TLSA Position: Q1 2023 in Review

HighTower Advisors sold out of Tiziana Life Sciences (TLSA) in Q1 2023, closing a stake of 4,130,001 shares — an estimated $2.47M sold.

HighTower Advisors first reported a position in TLSA in Q4 2018 and held it in 16 quarters. The position peaked at $13.3M in Q3 2020. 18 funds tracked by Wall St. Rank hold TLSA as of Q1 2023.

HighTower Advisors reported no remaining Tiziana Life Sciences position as of Q1 2023 after selling out during the quarter.
HighTower Advisors sold 4,130,001 Tiziana Life Sciences shares in Q1 2023, an estimated $2.47M.
HighTower Advisors first reported a position in Tiziana Life Sciences in Q4 2018 and held it in 16 quarters.
HighTower Advisors's Tiziana Life Sciences position peaked at $13.3M in Q3 2020.
18 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2023.

Based on HighTower Advisors's 13F filing for Q1 2023, filed 12 May 2023.